As government pricing, rebate programs, contracting requirements and regulatory expectations continue to evolve, pharmaceutical manufacturers need greater visibility and control across the revenue lifecycle. These are not separate problems. The same transaction data that proves your compliance also determines how much margin you keep, so a stale contract price or a misclassified customer surfaces twice: once as an audit finding, and once as cash already out the door. Informa’s MDRP Summit brings together government officials, industry leaders and pharmaceutical manufacturers to tackle these challenges, and we are looking forward to joining the conversation.
Whether you are evaluating your current revenue management environment, looking to reduce manual processes, or preparing for increasingly complex government pricing requirements, our team will be onsite to discuss how the iContracts Revenue Management Suite can help you close the gap between what you report and what you keep.
iContracts is purpose-built for pharmaceutical manufacturers, bringing commercial contracting, rebates, chargebacks, government pricing, state price transparency, Gross-to-Net analytics and more onto one integrated platform running on a single set of master data. That is what lets a chargeback correction protect your AMP, and a class of trade fix protect both.
Every year Medispend iContracts validates billions in chargeback credits for our customers and the government price calculations that depend on the same data.